Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene

Nuclear Medicine Communications

Volumn 27, Issue 10, 2006, Pages 773-777

  Kang, Joo Hyun ^a   Chung, June Key ^a   Lee, Yong Jin ^b   Kim, Kwang Il ^b   Jeong, Jae Min ^b   Lee, Dong Soo ^b   Lee, Myung Chul ^b  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Department of Nuclear Medicine ^*  (South Korea)

Author keywords

Breast cancer; Cis enhancer reporter system; Oestrogen receptor; Sodium iodide symporter (NIS)

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; IODINE 125; LIPOFECTAMINE; POTASSIUM PERCHLORATE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SODIUM IODIDE SYMPORTER; TAMOXIFEN;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CELL SELECTION; CELL STRAIN MCF 7; CONTROLLED STUDY; DOSE CALCULATION; DRUG RECEPTOR BINDING; ENHANCER REGION; ESTROGEN RESPONSIVE ELEMENT; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MOLECULAR IMAGING; MONITORING; PROTEIN EXPRESSION; REPORTER GENE; TOXICITY; TRANSCRIPTION INITIATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DNA; ESTRADIOL; GENES, REPORTER; HUMANS; IODINE RADIOISOTOPES; PROTEIN BINDING; RADIONUCLIDE IMAGING; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; SYMPORTERS; TAMOXIFEN; TRANSCRIPTION, GENETIC;

EID: 33748741534     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000230075.46694.8e     Document Type: Article

References (26)

1. Sommer S, Fuqua SA. Estrogen receptor and breast cancer. Semin Cancer Biol 2001; 11:339-352.
2. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002; 346:340-352.
3. Tremblay GB, Giguere V. Coregulators of estrogen receptor action. Crit Rev Eukaryot Gene Expr 2002; 12:1-22.
4. Lebowitz PF, Zujewski J. Hormonal therapy of breast cancer. Curr Probl Cancer 2003; 27:279-331.
5. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276:36869-36872.
6. Grese TA, Dodge JA. Selective estrogen receptor modulators (SERMs). Curr Pharm Des 1998; 4:71-92.
7. Vieja ADL, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 2000; 80:1083-1105.
8. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379:458-460.
9. − symporter (NIS): Implications for its secondary structure model. J Biol Chem 1998; 273:22657-22663.
10. Kang JH, Lee DS, Paeng JC, Lee JS, Kim YH, Lee YJ, et al. Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression. J Nucl Med 2005; 46:479-483.
11. Kim KI, Chung JK, Kang JH, Lee YJ, Shin JH, Oh HJ, et al. Visualization of endogenous p53-mediated transcription in vivo using sodium iodide symporter. Clin Cancer Res 2005; 11:123-128.
12. Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 2002; 43:1188-1200.
13. Doubrovin M, Ponomarev V, Beresten T, Balatoni J, Bornmann W, Finn R, et al. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci 2001; 98:9300-9305.
14. Ponomarev V, Doubrovin M, Lyddane C, Beresten T, Balatoni J, Bornman W, et al. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia 2001; 3:480-488.
15. So MK, Kang JH, Chung JK, Lee YJ, Shin JH, Kim KI, et al. In vivo imaging of retinoic acid receptor activity using a sodium/iodide symporter and luciferase dual imaging reporter gene. Mol Imaging 2004; 3:163-171.
16. − symporters for radioiodide concentrator gene therapy. J Nucl Med 2000; 41:1898-1904.
17. Weiss SJ, Philp NJ, Grollman EF. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 1984; 114:1090-1098.
18. Holinka cf, Hata H, Kuramoto H, Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). J Steroid Biochem 1986; 24:85-89.
19. Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J. Multifaceted regulation of cell cycle progression by estrogen: Regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol 2001; 21:794-810.
20. Clarke R, Skaar T, Baumann K, Leonessa F, James M, Lippman J, et al. Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res Treat 1994; 31:237-248.
21. Howell A. Future use of selective estrogen receptor modulators and aromatase inhibitors. Clin Cancer Res 2001; 7:4402s-4410s.
22. Ali S, Combos RC. Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2002; 2:101-112.
23. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AH, et al. Breast cancer: PET imaging of estrogen receptors. Radiology 1988; 169:45-48.
24. Zhang L, Adams JY, Billick E, Ilagan R, Iyer M, Le K, et al. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol Ther 2002; 5:223-232.
25. Iyer M, Wu L, Carey M, Wang Y, Smallwood A, Gambhir SS. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci 2001; 98:14595-14600.
26. Koch PE, Guo ZS, Kagawa S, Gu J, Roth JA, Fang B. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a Gal4 gene regulatory system. Mol Ther 2001; 3:278-283.